LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 35.03 | 84.90 | 3013 | 2991 | 1.0073 | 1.0028 | MN20160318_Q02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 35.03 | 84.90 | 130 | 2991 | 0.0435 | 0.0865 | MN20160318_Q02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 35.03 | 84.90 | 2601 | 2991 | 0.8695 | 0.9463 | MN20160318_Q02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 35.03 | 84.90 | 109 | 2991 | 0.0364 | 0.0498 | MN20160318_Q02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 35.03 | 84.90 | 2891 | 2991 | 0.9665 | 0.9868 | MN20160318_Q02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 36.73 | 84.90 | 3043 | 3254 | 0.9351 | 0.9746 | MN20160318_Q02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 36.73 | 84.90 | 3066 | 3254 | 0.9421 | 0.9775 | MN20160318_Q02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 36.73 | 84.90 | 3256 | 3254 | 1.0005 | 1.0002 | MN20160318_Q02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 36.73 | 84.90 | 3296 | 3254 | 1.0128 | 1.0048 | MN20160318_Q02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 36.73 | 84.90 | 168 | 3254 | 0.0516 | 0.1385 | MN20160318_Q02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 36.73 | 84.90 | 2789 | 3254 | 0.8570 | 0.9422 | MN20160318_Q02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 36.73 | 84.90 | 75 | 3254 | 0.0230 | -0.0233 | MN20160318_Q02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 36.73 | 84.90 | 3088 | 3254 | 0.9489 | 0.9802 | MN20160318_Q02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 38.43 | 84.90 | 3275 | 3459 | 0.9466 | 0.9796 | MN20160318_Q02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 38.43 | 84.90 | 3292 | 3459 | 0.9515 | 0.9815 | MN20160318_Q02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 38.43 | 84.90 | 3508 | 3459 | 1.0140 | 1.0052 | MN20160318_Q02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 38.43 | 84.90 | 3551 | 3459 | 1.0264 | 1.0098 | MN20160318_Q02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 38.43 | 84.90 | 170 | 3459 | 0.0491 | 0.1386 | MN20160318_Q02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 38.43 | 84.90 | 3006 | 3459 | 0.8689 | 0.9481 | MN20160318_Q02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 38.43 | 84.90 | 62 | 3459 | 0.0179 | -0.0571 | MN20160318_Q02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 38.43 | 84.90 | 3307 | 3459 | 0.9559 | 0.9832 | MN20160318_Q02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 40.14 | 84.90 | 3446 | 3682 | 0.9359 | 0.9758 | MN20160318_Q02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 40.14 | 84.90 | 3473 | 3682 | 0.9432 | 0.9786 | MN20160318_Q02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 40.14 | 84.90 | 3728 | 3682 | 1.0125 | 1.0046 | MN20160318_Q02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 40.14 | 84.90 | 3769 | 3682 | 1.0236 | 1.0086 | MN20160318_Q02 | D05 |